Arrowstreet Capital
EBS icon

Arrowstreet Capital’s Emergent Biosolutions EBS Stock Holding History

Arrowstreet Capital’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$118K Buy
+14,080
New +$118K ﹤0.01% 1872
2026
Q1 		– Sell
-54,835
Closed -$678K – 1916
2025
Q4 		$678K Buy
54,835
+21,128
+63% +$226K ﹤0.01% 1634
2025
Q3 		$297K Buy
+33,707
New +$262K ﹤0.01% 1764
2022
Q3 		– Sell
-15,945
Closed -$495K – 1320
2022
Q2 		$495K Buy
+15,945
New +$544K ﹤0.01% 1070
2019
Q1 		– Sell
-81,093
Closed -$4.81M – 1765
2018
Q4 		$4.81M Buy
81,093
+26,293
+48% +$1.69M 0.01% 585
2018
Q3 		$3.61M Buy
54,800
+27,608
+102% +$1.61M 0.01% 571
2018
Q2 		$1.37M Sell
27,192
-29,569
-52% -$1.54M ﹤0.01% 752
2018
Q1 		$2.99M Buy
+56,761
New +$2.83M 0.01% 672
2017
Q2 		– Sell
-290,266
Closed -$8.43M – 1129
2017
Q1 		$8.43M Buy
+290,266
New +$8.84M 0.03% 433
2016
Q4 		– Sell
-738,884
Closed -$23.3M – 1861
2016
Q3 		$23.3M Buy
738,884
+205,144
+38% +$5.96M 0.08% 256
2016
Q2 		$15M Buy
533,740
+223,380
+72% +$8.76M 0.05% 336
2016
Q1 		$11.3M Sell
310,360
-54,101
-15% -$1.91M 0.05% 340
2015
Q4 		$14.6M Sell
364,461
-16,562
-4% -$577K 0.07% 276
2015
Q3 		$10.9M Buy
381,023
+36,331
+11% +$1.2M 0.05% 322
2015
Q2 		$11.4M Buy
344,692
+112,638
+49% +$3.49M 0.06% 245
2015
Q1 		$6.67M Sell
232,054
-23,031
-9% -$661K 0.04% 355
2014
Q4 		$6.95M Buy
255,085
+69,999
+38% +$1.67M 0.04% 379
2014
Q3 		$3.94M Buy
185,086
+55,248
+43% +$1.27M 0.02% 444
2014
Q2 		$2.92M Sell
129,838
-3,951
-3% -$92K 0.02% 519
2014
Q1 		$3.38M Buy
133,789
+73,040
+120% +$1.84M 0.02% 524
2013
Q4 		$1.4M Buy
+60,749
New +$1.27M 0.01% 755

Other funds holding EBS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
OHA
Oak Hill Advisors New York $701M AUM 78.4% 1-Year Est. Return

Arrowstreet Capital's EBS Position: Q2 2026 in Review

Arrowstreet Capital opened a new position in Emergent Biosolutions (EBS) in Q2 2026: 14,080 shares worth $118K. The stake represents ﹤0.01% of the portfolio and ranks #1872 among its holdings. This is a return to the name: Arrowstreet Capital previously reported a position in EBS as recently as Q4 2025.

Arrowstreet Capital first reported a position in EBS in Q4 2013 and has held it in 21 quarters since. The position peaked at $23.3M in Q3 2016. 194 funds tracked by Wall St. Rank hold EBS as of Q2 2026.

  • Arrowstreet Capital held 14,080 shares of Emergent Biosolutions worth $118K as of Q2 2026.
  • Emergent Biosolutions was a new Arrowstreet Capital position in Q2 2026.
  • Emergent Biosolutions made up ﹤0.01% of Arrowstreet Capital's portfolio in Q2 2026, its #1872 holding.
  • Arrowstreet Capital first reported a position in Emergent Biosolutions in Q4 2013 and has held it in 21 quarters since.
  • Arrowstreet Capital's Emergent Biosolutions position peaked at $23.3M in Q3 2016.
  • 194 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2026.

Based on Arrowstreet Capital's 13F filing for Q2 2026, filed 13 Aug 2026.